Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 is now displayed on the page, replacing the previous v3.3.1. This appears to be a minor site version update without changes to the study content, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision: v3.3.1 replaces the previous Revision: v3.2.0 on the page, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page no longer displays the government funding operating status notice.SummaryDifference0.4%

- Check35 days agoChange DetectedScreenshots show minor visual and layout updates to the Study Details page without changes to inclusion criteria, interventions, outcomes, or important dates.SummaryDifference0.5%

- Check64 days agoChange DetectedKey updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).SummaryDifference4%

- Check71 days agoChange DetectedThe page updates the revision from v3.0.2 to v3.1.0, signaling a new version is available. No other substantive content changes are evident.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.